Czechia, May 11 -- Czechia based PROMEDICA PRAHA GROUP, a.s. has secured contract from Revmatologicky ustav for Antineoplastic and immunomodulating agents - Drug deliveries - AVTOZMA 2026. The value of the contract is worth 4874100000 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....